The traditional Chinese medicine Fuzi improves lipid metabolism disorders in mice with Yang deficiency and hyperlipidaemia by modulating the PKA – PPARα–carnitine palmitoyltransferase 1α (CPT1α) pathway. The gene discussed is CPT1A; the disease is hyperlipidemia.